Menu Search
Equities

Rockwell Medical Inc

RWMA:FRA

Rockwell Medical Inc

Actions
  • Price (EUR)3.58
  • Today's Change0.084 / 2.40%
  • Shares traded3.00k
  • 1 Year change+92.99%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 07:07 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Rockwell Medical Inc grew revenues 14.84% from 72.81m to 83.61m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -18.68m to -8.44m.
Gross margin13.44%
Net profit margin-5.06%
Operating margin-3.28%
Return on assets-10.48%
Return on equity-28.90%
Return on investment-16.25%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Rockwell Medical Inc fell by 1.12m. Cash Flow from Financing totalled 11.34m or 13.57% of revenues. In addition the company used 9.41m for operations while cash used for investing totalled 3.05m.
Cash flow per share-0.0717
Price/Cash flow per share--
Book value per share0.7573
Tangible book value per share0.3898
More ▼

Balance sheet in USDView more

Rockwell Medical Inc has a Debt to Total Capital ratio of 31.44%, a lower figure than the previous year's 68.75%.
Current ratio2.00
Quick ratio1.60
Total debt/total equity0.4586
Total debt/total capital0.3144
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.